PATENT CLAIM ANALYSIS

Application Number: 15514244
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2017-10
Patent Classification: ["514", "009500"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating peripheral vascular disease, the composition comprising, as an active ingredient: (a) hepatocyte growth factor (HGF) or an isoform thereof, and stromal cell derived factor 1α (SDF-1α); or (b) a polynucleotide encoding the HGF and a polynucleotide encoding the SDF-1α. The peripheral vascular disease (for example, ischemic limb disease) can be more effectively prevented or treated through the significant promotion of vascular endothelial cell migration and angiogenesis in the case of singly using the composition of the present invention than in the case of using HGF, an isoform thereof, SDF-1α or a polynucleotide codes a protein thereof.

Claim (Index 3):
The composition of  claim 1 , wherein the isoform of the HGF comprises full-length HGF (flHGF) and deleted variant HGF (dHGF).

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.96923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15030999', '14495614', '12998075', '14355792', '09175713']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7640552013255792
- 35 USC 102 Novelty (BERT): 0.5137631815278554
- Combined Prediction Score: 0.7390259993458069
- Mean Citation Score: 238.13711000000004
- Max Citation Score: 268.15457000000004
- Similarity Product: 173.04699308995131

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test